Acceleron Pharma Inc EV/Sales
¿Qué es el EV/Sales de Acceleron Pharma Inc?
El EV/Sales de Acceleron Pharma Inc es 91.88
¿Cuál es la definición de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales de compañías en Sector Health Care en NASDAQ en comparadas con Acceleron Pharma Inc
¿Qué hace Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Empresas con ev/sales similar a Acceleron Pharma Inc
- Eaton Vance Tax-Managed Global Diversified Equity Income Fund tiene EV/Sales de 90.79
- genedrive plc tiene EV/Sales de 90.81
- Royce Micro-Cap Trust Inc tiene EV/Sales de 91.14
- Fairfax India tiene EV/Sales de 91.22
- Honda Motor tiene EV/Sales de 91.24
- Novonix tiene EV/Sales de 91.58
- Acceleron Pharma Inc tiene EV/Sales de 91.88
- China Huarong tiene EV/Sales de 91.97
- Zeotech tiene EV/Sales de 92.09
- Castillo Copper tiene EV/Sales de 92.20
- Carnival International tiene EV/Sales de 92.27
- Imagion Biosystems tiene EV/Sales de 92.51
- Syntonic tiene EV/Sales de 92.53